RADICAL PROSTATECTOMY WITH EXTENDED PELVIC LYMPHADENECTOMY AND ADJUVANT HORMONAL THERAPY IN PATIENTS WITH LYMPHOGENIC DISSEMINATED PROSTATE CANCER

The main radical treatments for patients with prostate cancer (PC) are radical prostatectomy (RPE) and radiotherapy. At the same time pelvic lymphadenectomy (PLAE) in patients with PC is an important diagnostic step during both surgical and radiation treatments. The main goal of PLAE is to evaluate...

Full description

Bibliographic Details
Main Authors: B. Ya. Alekseev, K. M. Nyushko
Format: Article
Language:Russian
Published: ABV-press 2014-08-01
Series:Onkourologiâ
Subjects:
Online Access:http://oncourology.abvpress.ru/index.php/oncur/article/view/246
id doaj-3e7d9018a78a494db546b44d7a6a7a8d
record_format Article
spelling doaj-3e7d9018a78a494db546b44d7a6a7a8d2020-11-25T00:12:30ZrusABV-pressOnkourologiâ 1726-97761996-18122014-08-0173118121261RADICAL PROSTATECTOMY WITH EXTENDED PELVIC LYMPHADENECTOMY AND ADJUVANT HORMONAL THERAPY IN PATIENTS WITH LYMPHOGENIC DISSEMINATED PROSTATE CANCERB. Ya. Alekseev0K. M. Nyushko1P.A. Herzen Moscow Oncology Research Institute, MoscowP.A. Herzen Moscow Oncology Research Institute, MoscowThe main radical treatments for patients with prostate cancer (PC) are radical prostatectomy (RPE) and radiotherapy. At the same time pelvic lymphadenectomy (PLAE) in patients with PC is an important diagnostic step during both surgical and radiation treatments. The main goal of PLAE is to evaluate the pelvic lymph nodes. The paper gives the data of a number of trials of the efficiency of RPE with extended PLAE and adjuvant hormonal therapy.http://oncourology.abvpress.ru/index.php/oncur/article/view/246prostate cancerradical prostatectomyhormonal therapylymph nodes, survival
collection DOAJ
language Russian
format Article
sources DOAJ
author B. Ya. Alekseev
K. M. Nyushko
spellingShingle B. Ya. Alekseev
K. M. Nyushko
RADICAL PROSTATECTOMY WITH EXTENDED PELVIC LYMPHADENECTOMY AND ADJUVANT HORMONAL THERAPY IN PATIENTS WITH LYMPHOGENIC DISSEMINATED PROSTATE CANCER
Onkourologiâ
prostate cancer
radical prostatectomy
hormonal therapy
lymph nodes, survival
author_facet B. Ya. Alekseev
K. M. Nyushko
author_sort B. Ya. Alekseev
title RADICAL PROSTATECTOMY WITH EXTENDED PELVIC LYMPHADENECTOMY AND ADJUVANT HORMONAL THERAPY IN PATIENTS WITH LYMPHOGENIC DISSEMINATED PROSTATE CANCER
title_short RADICAL PROSTATECTOMY WITH EXTENDED PELVIC LYMPHADENECTOMY AND ADJUVANT HORMONAL THERAPY IN PATIENTS WITH LYMPHOGENIC DISSEMINATED PROSTATE CANCER
title_full RADICAL PROSTATECTOMY WITH EXTENDED PELVIC LYMPHADENECTOMY AND ADJUVANT HORMONAL THERAPY IN PATIENTS WITH LYMPHOGENIC DISSEMINATED PROSTATE CANCER
title_fullStr RADICAL PROSTATECTOMY WITH EXTENDED PELVIC LYMPHADENECTOMY AND ADJUVANT HORMONAL THERAPY IN PATIENTS WITH LYMPHOGENIC DISSEMINATED PROSTATE CANCER
title_full_unstemmed RADICAL PROSTATECTOMY WITH EXTENDED PELVIC LYMPHADENECTOMY AND ADJUVANT HORMONAL THERAPY IN PATIENTS WITH LYMPHOGENIC DISSEMINATED PROSTATE CANCER
title_sort radical prostatectomy with extended pelvic lymphadenectomy and adjuvant hormonal therapy in patients with lymphogenic disseminated prostate cancer
publisher ABV-press
series Onkourologiâ
issn 1726-9776
1996-1812
publishDate 2014-08-01
description The main radical treatments for patients with prostate cancer (PC) are radical prostatectomy (RPE) and radiotherapy. At the same time pelvic lymphadenectomy (PLAE) in patients with PC is an important diagnostic step during both surgical and radiation treatments. The main goal of PLAE is to evaluate the pelvic lymph nodes. The paper gives the data of a number of trials of the efficiency of RPE with extended PLAE and adjuvant hormonal therapy.
topic prostate cancer
radical prostatectomy
hormonal therapy
lymph nodes, survival
url http://oncourology.abvpress.ru/index.php/oncur/article/view/246
work_keys_str_mv AT byaalekseev radicalprostatectomywithextendedpelviclymphadenectomyandadjuvanthormonaltherapyinpatientswithlymphogenicdisseminatedprostatecancer
AT kmnyushko radicalprostatectomywithextendedpelviclymphadenectomyandadjuvanthormonaltherapyinpatientswithlymphogenicdisseminatedprostatecancer
_version_ 1725399336288780288